“Lyme & Reason: Battles & Breakthroughs Against Lyme Disease” has been nominated as a finalist for the 2020 Sharecare Awards , in partnership with the National Academy of Television Arts & Sciences, New York Chapter, renowned for the Emmy Awards. This is a great opportunity for the Lyme community to raise awareness about Lyme and other tick-borne diseases.
Vote Now! Click here to vote for “Lyme & Reason” The public can vote one time per day until January 31st 1 vote per category, per calendar day, per device “Lyme & Reason: Battles & Breakthroughs Against Lyme Disease” has been nominated as a finalist for the 2020 Sharecare Awards, in partnership with
The Asian longhorned tick, Haemaphysalis longicornis, first detected in New Jersey in 2017, has since been recorded from 88 counties across 12 eastern states. This highly invasive tick is able to reproduce asexually and is considered an important vector of human pathogens in it native range of Asia. Since it’s detection in the US, many […]
LDA 2019 Grants/Non-Lyme TBDs Rising/Fallon Post Treatment Lyme Study/Chronic Lyme in House Language/Rodent Bait Vaccine
LDA strives to fund the most relevant and cutting edge research aimed at investigating the diagnosis, treatment, pathology, and prevention of Lyme and other tick-borne diseases. The goal is to have researchers publish in peer review and move the field of tick-borne diseases forward. To date, LDA has 53 peer-reviewed publications that have resulted from its supported research.
The 116th Congress House Committee on Appropriations submitted a report in explanation of bill H.R. 2740, the Omnibus that funds Health and Human Services (HHS) including the National Institute of Health (NIH) and the Centers for Disease Control (CDC), and outlines the final legislative language and designation of funds for vector-borne diseases, including Lyme disease, […]
The Connecticut Agricultural Experiment Station (CAES) and US Biologic, Inc. released the publication of a field trial study showing the effectiveness of an orally-delivered anti-Lyme vaccine that targets the white-footed mouse, the major wildlife source of Lyme disease. The study took place in the residential area of Redding, CT, over a three-year time period and […]
A study by Elizabeth Lee-Lewandrowski, PhD, MPH, et al, published in The American Journal of Clinical Pathology from the Department of Pathology, Massachusetts General Hospital and Harvard Medical School, evaluated trends in non-Lyme disease tick-borne disease (NLTBI) blood testing at Quest Diagnostics laboratory located in New Jersey. The study took place over the course of […]
Brian A. Fallon, Barbara Strobino et al. released the results of a recent study in Brain, Behavior, & Immunity – Health. The article was published on January 7, 2020 and is titled “Anti-lysoganglioside and other anti-neuronal autoantibodies in post-treatment Lyme Disease and Erythema Migrans after repeat infection”. Excerpts from the Abstract: Background: Molecular mimicry targeting […]
Brian A. Fallon, Nevena Zubcevik et al. published an article in Frontiers in Medicine, December 6, 2019, The General Symptom Questionnaire-30 (GSQ-30): A Brief Measure of Multi-System Symptom Burden in Lyme Disease. Conclusions and Relevance of the study: “The GSQ-30 is a valid and reliable instrument to assess symptom burden among patients with acute and […]
Help Us Work for You/Tick Act Becomes Law/ILADS Defines CLD/TBDWG 2020 Meeting/Torrey Lawsuit Update
Help Us Work for You! Let’s Provide a Healthier New Year. This year has been another busy one for the Lyme Disease Association (LDA). We have now been working for Lyme and tick-borne diseases (TBD) for 29 years, with individuals who are patients and family members of patients driving the programs. We care about you, your family, your friends, your pets, who have or might acquire Lyme disease and other TBD. That is why 97% of our funds go directly to programs most years. By donating today you can help us continue our programs to help Lyme patients.